We serve Chemical Name:Org-12962 CAS:132834-56-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Org-12962
CAS.NO:132834-56-1
Synonyms:Org-12962
Molecular Formula:C10H11ClF3N3
Molecular Weight:265.66300
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:286.004ºC at 760 mmHg
Density:1.454g/cm3
Index of Refraction:1.541
PSA:28.16000
Exact Mass:265.05900
LogP:2.55720
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Org-12962 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Org-12962 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Org-12962 Use and application,Org-12962 technical grade,usp/ep/jp grade.
Related News: There are more than 4,700 different PFAS chemical compounds, researchers said. Since the 1950s, they have been widely used in a number of consumer products, including stain-repellent fabrics, nonstick cookware, polishes, waxes, paints and cleaning products, according to the U.S. Environmental Protection Agency. Org-12962 manufacturer Immediately thereafter, the iLet begins controlling blood-sugar levels automatically, without requiring the user to count carbohydrates, set insulin delivery rates, or deliver bolus insulin for meals or corrections. Org-12962 supplier In order to find answers to these questions, our staff in the development department set about conducting a series of experiments. Org-12962 vendor Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase. Org-12962 factory The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.
